Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Carcinoma × Bevacizumab × Clear all

Status

Completed 5 Active not recruiting 3 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 65 Carcinoma, Hepatocellular 40 Ovarian Neoplasms 36 Carcinoma, Non-Small-Cell Lung 24 Neoplasms 18 Fallopian Tube Neoplasms 15 Breast Neoplasms 14 Lung Neoplasms 12 Endometrial Neoplasms 11 Liver Neoplasms 10 Glioblastoma 10 Colonic Neoplasms 10 Uterine Cervical Neoplasms 9 Triple Negative Breast Neoplasms 9 Rectal Neoplasms 9 Brain Neoplasms 9 Neoplasm Metastasis 8 Stomach Neoplasms 7 Colorectal Cancer Metastatic 7 Advanced Solid Tumors 7 Pancreatic Neoplasms 5 Melanoma 5 Carcinoma, Renal Cell 5 Carcinoma, Ovarian Epithelial 5 Solid Tumor 4 Recurrence 4 Meningeal Carcinomatosis 4 Glioma 4 Biliary Tract Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3

Interventions

pembrolizumab 11 Cisplatin 11 Specimen Handling 8 Magnetic Resonance Spectroscopy 8 durvalumab 4 Platinum 4 Pemetrexed 4 Paclitaxel 4 Cyclophosphamide 4 1,2-diaminocyclohexaneplatinum II citrate 4 fludarabine 3 cemiplimab 3 Radiotherapy, Intensity-Modulated 3 Radiotherapy 3 Oxaliplatin 3 Nivolumab 3 Fluorouracil 3 Carboplatin 3 Biopsy 3 poly ICLC 2 osimertinib 2 cabozantinib 2 atezolizumab 2 Heavy Ion Radiotherapy 2 Gemcitabine 2 Drug Therapy 2 Docetaxel 2 Cetuximab 2 Capecitabine 2 zipalertinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06827353 2025-02-14

OVNI-B

Centre Hospitalier Universitaire de Nīmes

Carcinoma, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡